Elder Pharmaceuticals (Delisted) share price history
BSE: 532322
Last traded ₹38.00 on 12 Sep 2016
Delisted on 11 May 2018.
Last announcements
The company's own last announcements before its shares stopped trading, routine notices left out.Share news and announcements
May 2018
Feb 2018
Jun 2017
5 Jun · Legal
Exchange has sought clarification from Elder Pharmaceuticals Ltd with respect to news article appearing on business-standard.com on June 2, 2017 titled "Elder Pharma files for insolvency." ....5 Jun · Legal
Exchange has sought clarification from the Company with respect to news item captioned "Elder Pharma files for Insolvency". In this regard, Exchange has advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company is aware of any information that has not been announced to the Exchanges under regulation 30 of Listing Regulations. The response from the Company is awaited.
Jul 2016
21 Jul · Legal
Exchange has sought clarification from Elder Pharmaceuticals Ltd with respect to news article appearing on Moneylife on July 21, 2016 titled "Elder Pharma, embroiled in bribery case, ....21 Jul · Legal
Exchange has sought clarification from Elder Pharmaceuticals Limited with respect to recent news item captioned 'Elder Pharma, embroiled in bribery case, is among the biggest defaulters and the Ministry is doing nothing'. In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company are aware of any information that has not been announced to the Exchanges under regulation 30 of Listing regulations. The response from the Company is awaited.
Results
Standalone; ₹ crore, the charts by years to March, then June, the table by quarter. No standalone results on record for the year to Jun 2013.Quarterly results
Quarter to Mar 2015, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹24 Crdown 31.41%
- Net profitNet profit. Under it, net profit in the quarter before. A change in per cent is not worked out where either period is a loss or nothing.
- −₹51 CrQuarter to Dec 2014: −₹73 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- −210.0%
Revenue by year
Net profit by year, a loss in red
The company moved its year end from March to June: its last year to March on record ended in Mar 2012, its first year to June in Jun 2014.
The years either side of a change of basis do not compare. From the year to Mar 2009, the company's revenue for that year, ₹620 Cr, differs from its quarters added, ₹609 Cr.
| ₹ crore | Jun 2013 | Sep 2013 | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 189 | 153 | 138 | 102 | 91 | 84 | 36 | 24 |
| Net profit | 7 | 4 | −21 | −75 | 109 | −47 | −73 | −51 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | 3.6% | 2.5% | −15.5% | −74.0% | 120.1% | −55.8% | −205.3% | −210.0% |
Standalone. The last eight quarters. The latest is shaded.
Where the return came from
Yearly rates to Jun 2014, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −33.3% | – | – | 0.0% |
| 3 years | −17.4% | – | – | 0.0% |
| 5 years | −1.9% | – | – | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth and the change in P/E are left empty where earnings per share at either end of the window was a loss or is not on record.
Elder Pharmaceuticals share price by year
Each calendar year to 2016.
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2016 | 38.00 | −49.5% | 78.15 | 21.40 |
| 2015 | 75.30 | −27.7% | 162.85 | 68.30 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. The 2016 close is its last trade, on 12 Sep 2016.
Recent sessions
The last 10 trading days to 12 Sep 2016, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 12 Sep 2016 | 38.00 | 38.00 | 38.00 | 38.00 | 38.00 | 4,600 |
| 6 Sep 2016 | 34.50 | 36.20 | 32.80 | 36.20 | 35.45 | 17,537 |
| 29 Aug 2016 | 33.00 | 34.50 | 33.00 | 34.50 | 34.48 | 5,274 |
| 22 Aug 2016 | 32.80 | 32.90 | 32.05 | 32.90 | 32.69 | 3,905 |
| 16 Aug 2016 | 31.35 | 31.35 | 29.90 | 31.35 | 31.34 | 4,215 |
| 8 Aug 2016 | 29.90 | 29.90 | 29.90 | 29.90 | 29.90 | 2,474 |
| 1 Aug 2016 | 28.50 | 28.50 | 28.50 | 28.50 | 28.50 | 1,590 |
| 25 Jul 2016 | 27.15 | 27.15 | 27.15 | 27.15 | 27.15 | 3,044 |
| 18 Jul 2016 | 25.90 | 25.90 | 25.90 | 25.90 | 25.90 | 4,829 |
| 11 Jul 2016 | 24.70 | 24.70 | 24.70 | 24.70 | 24.70 | 356 |
Prices in ₹ per share as traded, not adjusted.
Company details
- Legal name
- Elder Pharmaceuticals Ltd
- BSE code
- 532322
- ISIN
- INE975A01015
- Face value
- ₹10
- Former symbols
- ELDERPHARM
- CIN
- L24239MH1983PLC029714
- Corporate identity number, the registrar of companies' code for it